Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and Social Attention in Healthy Men
NCT07093060Phase 1Recruiting
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Jun 2025
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD) (5 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoints: Fixation duration and Fixation counts. Started Jun 2025; status: recruiting.
02
Drugs
oxytocin nasal spray
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT07093060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07093060.